Skip to main content

World’s First Malaria Vaccine RTS,S Launched In Malawi

World’s First Malaria Vaccine RTS,S Launched In Malawi

Written on 04/29/2019


World’s First Malaria Vaccine RTS,S Launched In Malawi
25th April 2019 On World Malaria Day, the world’s first malaria vaccine was launched in Malawi – Africa in a pilot programme. The country is the very first in Africa where this Malaria Vaccine: RTS,S has been introduced for children up to 2 years of age. Kenya and Ghana will introduce the vaccine in the forthcoming weeks.
Malaria is one of the world’s most dreadful disease, with a death rate of 1 child every two minutes all over the globe. Kids under 5 year age are at major risk of its complications. Worldwide, malaria kills 435 000 people per year with most of them being children.
The WHO-coordinated pilot programme is a collaborative effort with ministries of health from Ghana, Kenya and Malawi and a range of in-country and worldwide partners, such as PATH, a nonprofit organization, and GSK, the vaccine developer and producer, which is donating up to 10 million vaccine doses with this pilot.
It required more than 30 years and nearly $1 billion to develop a vaccine against malaria.
The vaccine – RTS, S is only valuable for kids younger than 2 who receive four doses, in the ages of 5 weeks, 6 months, 7 months and 22 weeks.
RTS,S/AS01 (commercial title: Mosquirix), was engineered with genes from the outer protein of P. falciparum malaria parasite along with a portion of a hepatitis B virus plus a chemical adjuvant to improve the immune reaction.
“We salute WHO and Malawi for their leadership in recognizing this historical landmark,” said Steve Davis, President, and CEO of PATH,” and we look forward to the beginning of Legislation in Ghana, and then Kenya later this year. A vaccine for malaria is among many innovations required to bring an end to this disease, and we stand with all countries as well as our many partners in progressing towards a malaria-free world”
The malaria vaccine pilot intends to reach over the three countries roughly 360,000 children each year. Ministries of health will determine where the vaccine will be awarded; they’ll focus on areas with moderate-to-high malaria transmission.
“Introducing the world’s first malaria vaccine will reduce the burden of a few of the most dreadful health issue faced globally. This publication tool is the consequence of GSK workers cooperating with their partners, applying the latest in vaccine science to contribute to the fight against malaria,” said Dr. Thomas Breuer, Chief Medical Officer of GSK Vaccines. “We look forward to viewing the outcomes of the pilot, also in parallel, we are working with WHO and PATH to secure the vaccine’s continuing international health effect in the future.”
Financing for the pilot programme was mobilized through an unprecedented alliance among three key health funding bodies: Gavi, the Vaccine Alliance; the Global Fund to Fight AIDS, Tuberculosis, and Malaria; and United. Additionally,WHO, PATH and GSK are supplying in-kind contributions.

Comments

Popular posts from this blog

Beer production

Brewing  is the production of  beer  by steeping  a  starch  source (commonly cereal  grains, the most popular of which is  barley ) [1]  in water and  fermenting  the resulting sweet liquid with  yeast . It may be done in a  brewery  by a commercial brewer, at home by a  homebrewer , or by a variety of traditional methods such as communally by the  indigenous peoples in Brazil  when making  cauim . [2]  Brewing has taken place since around the 6th millennium BC, and archaeological evidence suggests that emerging civilizations including  ancient Egypt [3] and  Mesopotamia  brewed beer. [4]  Since the nineteenth century the  brewing industry  has been part of most western economies. The basic ingredients of beer are water and a  fermentable  starch source such as  malted barley . Most beer is fermented with a  brewer's yeast  and flavoured with  hops . [5]  Less widely used starch sources include  millet ,  sorghum and  cassava . [6]  Secondary sources ( adjuncts ), such as

Mechanism of Action of Hydroxychloroquine as an Antirheumatic Drug

Mechanism of Action of Hydroxychloroquine as an Antirheumatic Drug Abstract The antimalarial agents chloroquine and hydroxychloroquine have been used widely for the treatment of rheumatoid arthritis and systemic lupus erythematosus. These compounds lead to improvement of clinical and laboratory parameters, but their slow onset of action distinguishes them from glucocorticoids and nonsteroidal antiinflammatory agents. Chloroquine and hydroxychloroquine increase pH within intracellular vacuoles and alter processes such as protein degradation by acidic hydrolases in the lysosome, assembly of macromolecules in the endosomes, and posttranslation modification of proteins in the Golgi apparatus. It is proposed that the antirheumatic properties of these compounds results from their interference with "antigen processing" in macrophages and other antigen-presenting cells. Acidic cytoplasmic compartments are required for the antigenic protein to be digested and for the pept

HAZARD ANALYSIS AND CRITICAL CONTROL POINT (HACCP) SYSTEM AND GUIDELINES FOR ITS APPLICATION. And All HACCP concept And Conclusion

All Concept of HACCP PREAMBLE The first section of this document sets out the principles of the Hazard Analysis and Critical Control Point (HACCP) system adopted by the Codex Alimentarius Commission. The second section provides general guidance for the application of the system while recognizing that the details of application may vary depending on the circumstances of the food operation The HACCP system, which is science based and systematic, identifies specific hazards and measures for their control to ensure the safety of food. HACCP is a tool to assess hazards and establish control systems that focus on prevention rather than relying mainly on end-product testing. Any HACCP system is capable of accommodating change, such as advances in equipment design, processing procedures or technological developments. HACCP can be applied throughout the food chain from primary production to final consumption and its implementation should be guided by scientific evidence of risks to human health